Epidural Abscess Treatment Market Size & Share, by Type (Intracranial, Intraspinal); Treatment (Antifungal Drugs, Antibiotics, Surgery); End-user (Hospital, Pharmacy, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3437
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Epidural Abscess Treatment Market size is expected to cross USD 81 billion by the end of 2035, growing at a CAGR of 9% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of epidural abscess treatment was over USD 38 billion. The growth of the market can be attributed to the increasing stances of epidural abscesses throughout the world. For instance, in 2022, around 0.7 to 1.8 cases of spinal epidural abscesses were reported for every 10,000 hospital admissions across the globe. Furthermore, the rapid increase in medical research and development activities and the significant rise in the aged populace are also estimated to drive market growth over the forecast period.

In addition to these, factors that are believed to fuel the market growth of epidural abscess treatment include the worldwide expansion in spinal surgeries. For instance, globally approximately 350 million spinal surgeries were performed in 2022. In addition to this, rising risks of infection caused by back and head surgeries are also estimated to boost the market growth in the coming years. Besides this, the surging cases of chronic ear infections are also anticipated to fuel the market growth as the such infection starts with swelling, severe pain, or an infection behind the eardrum which can permanently damage the eardrum.


Epidural Abscess Treatment Market
Get more information on this report: Request Free Sample PDF

Epidural Abscess Treatment Sector: Growth Drivers and Challenges

Growth Drivers

  • The Surge in Head Surgeries – Several kinds of head surgeries are performed to treat numerous conditions related to the brain and head. Head surgeries such as craniotomy, craniectomy, biopsy, and so on have been done to treat the conditions such as brain aneurysms, defective brain tissues, brain tumors, and other neurological disorders, and so on. These surgical processes have huge chances of developing epidural abscesses over time. Hence, this factor is estimated to fuel the market growth in the projected time frame. For instance, globally over 15 million people require head surgery as of the increasing ratio of several neurological disorders.
  • Rising Cases of Otitis Media – Otitis media is a chronic ear infection that causes fluid, inflammation or an infection behind the eardrum. Recurring ear infection, and acute ear infection that does not heal completely cause chronic ear infection. A prolonged condition of such chronic ear infection can lead to the staphylococcus aureus bacterial infection which causes an epidural abscess. Hence, this factor is estimated to drive market growth in the coming years. For instance, by 2022, the frequency of chronic otitis media increased to around 680 people per 100,000 individuals throughout the world.
  • Increasing Ratio of Traumatic Brain Injury - A traumatic brain injury (TBI) is a sudden injury that causes brain damage. It can happen as a result of a jolt, bump, or blow to the head. Many times, such an injury can cause a severe kind of infection that may develop into an epidural abscess over time. This, as a factor, is also anticipated to drive market growth over the projected time frame. For instance, an estimated 1.8 million people in the US survive traumatic brain injuries each year.
  • An Escalating Investment in R&D Activities - For instance, the pharmaceutical industry invested roughly ~USD 86 billion in research and development activities in 2019. These expenses were incurred for a variety of operations, such as drug development and testing, clinical studies for safety evaluation, and so on.
  • Rising Ratio of People Who Inject Drugs – According to the World Health Organization report, around 11 million people worldwide inject drugs.

Challenges

  • Difficult Diagnosis of Abscess - A spinal epidural abscess is challenging to identify and needs a high level of awareness. A spinal epidural abscess can result in substantial morbidity and mortality if left untreated. Hence, this factor is estimated to hinder market growth in the coming years.
  • High Cost of Surgical Treatment of Epidural Abscess
  • Lack of Awareness Regarding the Epidural Abscess in Emerging Nations

Epidural Abscess Treatment Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~9%

Base Year Market Size (2022)

~ USD 38 Billion

Forecast Year Market Size (2035)

~ USD 81 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Epidural Abscess Treatment Segmentation

End-user (Hospital, Pharmacy, Specialty Clinics)

The global epidural abscess treatment market is segmented and analyzed for demand and supply by end-user into hospital, pharmacy, specialty clinics, and others. Out of these four types of segments, the hospital segment is estimated to gain the largest market share of about ~41% in the year 2035. The growth of the segment can be attributed to the increasing healthcare expenditure, followed by the surging cases of epidural abscess, and the surging ratio of people who require immediate treatment for this condition. For instance, in 2021, an increase of approximately 2% to 5% was reported in intracranial epidural abscess (IEAs) cases throughout the world. In addition to this, an expansion in awareness about epidural abscesses in developed countries is also estimated to propel the segment growth in the projected time frame.

Treatment (Antifungal Drugs, Antibiotics, Surgery)

The global epidural abscess treatment market is also segmented and analyzed for demand and supply by treatment into antifungal drugs, antibiotics, and surgery. Amongst these three segments, the surgery segment is expected to garner a significant share of around ~75% in the year 2035. The growth of the segment can be credited to the rising patient pool with spinal epidural abscesses (SEAs), which mostly seek surgical treatment for a better cure of the such condition. Moreover, the higher efficacy of surgical procedures including decompressions, and open or minimally invasive procedures to treat the spinal epidural abscess is also anticipated to drive the segment growth over the projected time frame. On the other hand, the antibiotics segment is projected to witness a massive CAGR during the forecast period, owing to the rising usage of antibiotics in the effective treatment of epidural abscesses in conjunction with surgical procedures. The normal duration of antibiotic treatment is nearly 3 to 4 weeks to treat a patient with an epidural abscess. Besides this, some spinal epidural abscesses can be treated by only giving a dose of antibiotics for around 4-6 weeks.

Our in-depth analysis of the global market includes the following segments:

        By Type

  • Intracranial
  • Intraspinal

       By Treatment

  • Antifungal Drugs
  • Antibiotics
  • Surgery

         By End-User

  • Hospital
  • Pharmacy
  • Specialty Clinics
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Epidural Abscess Treatment Industry - Regional Synopsis

North American Market Forecast

The market share of epidural abscess treatment in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~38% by the end of 2035. The growth of the market can be attributed majorly to the high healthcare expenditure, followed by the rising frequency of epidural abscess cases in the region. According to the Centers for Medicare and Medicaid Services (CMS), healthcare expenditure in the United States expanded by 2.7% to USD 4.3 trillion in 2021. This healthcare investment accounted for 18.3% of the nation's GDP. In addition to this, rising awareness in people regarding the epidural abscess, coupled with the surge in early detection and treatment for such conditions is also anticipated to accelerate the market growth further over the forecast period in the region. Moreover, the increasing ratio of people who inject drugs is also projected to drive market growth further in the region.

APAC Market Statistics

The Asia Pacific epidural abscess treatment market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the increasing frequency of infection cases owing to the surge in the geriatric population, as their immunity is compromised. Based on the World Bank statistics, the population above 65 years of age in India expanded by 90,719,952 in 2020, while, it expanded by 167,808,567 in China. Moreover, rising investment in R&D activities and improving medical facilities are estimated to boost market growth. In addition to this, a notable increase in head and spinal surgeries is also estimated to boost the market growth in the APAC region over the projected time frame.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share of about ~20% by the end of 2035. The growth of the market can be attributed majorly to the expanding stances of head surgeries, coupled with the significant expansion in traumatic brain injury (TBI) cases, coupled with the surge in research and development activities. Moreover, the radically increasing frequency of acute otitis media in younger people in Germany is also projected to drive the growth of the epidural abscess treatment market in the European region throughout the forecast period.

Research Nester
Epidural Abscess Treatment Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Epidural Abscess Treatment Landscape

top-features-companies
    • Alembic Limited
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eli Lilly and Company
    • Sandoz Inc.
    • Sun Pharmaceutical Industries Limited
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Siemens Healthcare GmbH

In the News

  • Sun Pharmaceutical Industries Limited has completed the acquisition of Concert Pharmaceuticals, Inc., which is a leading clinical biopharmaceutical company.

  • Sandoz Inc. introduced Ciprofloxacin 0.3% + Dexamethasone 0.1% otic suspension in the United States for the treatment of bacterial infections such as acute otitis media and acute otitis externa.

Author Credits:  Radhika Pawar


  • Report ID: 3437
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The surge in head surgeries, rising cases of otitis media, and increasing ratio of traumatic brain injury are the major factors driving the market growth.

The market size of epidural abscess treatment is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2023-2035.

Difficult diagnosis of abscess, high cost of surgical treatment of epidural abscess, and lack of awareness regarding the epidural abscess in emerging nations are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Alembic Limited, Eli Lilly and Company, Sandoz Inc., Sun Pharmaceutical Industries Limited, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Pfizer Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, treatment, end-user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Epidural Abscess Treatment Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying